128 related articles for article (PubMed ID: 8879880)
21. Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
Stokkel MP; Reigman HI; Verkooijen RB; Smit JW
J Cancer Res Clin Oncol; 2003 May; 129(5):287-94. PubMed ID: 12750997
[TBL] [Abstract][Full Text] [Related]
22. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
[No Abstract] [Full Text] [Related]
23. An aggressive radio-resistant papillary thyroid cancer.
Mehta RS; Negin B; Popii V; Langer C
Clin Adv Hematol Oncol; 2008 Oct; 6(10):761-7. PubMed ID: 18997667
[No Abstract] [Full Text] [Related]
24. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
Zakavi SR; Kakhki VD
Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
[No Abstract] [Full Text] [Related]
25. Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.
Tuncel M; Ozgen Kiratli P
Rev Esp Med Nucl; 2007; 26(4):226-9. PubMed ID: 17662189
[No Abstract] [Full Text] [Related]
26. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
Wu X; Gu H; Gao Y; Li B; Fan R
Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
[TBL] [Abstract][Full Text] [Related]
27. [Iodine scintigraphy of differentiated thyroid carcinoma].
Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
[No Abstract] [Full Text] [Related]
28. Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma.
Walter MA; Wild D; Rasch H; Müller-Brand J; Müller B; Bilz S
Thyroid; 2006 Oct; 16(10):1063-4. PubMed ID: 17042695
[No Abstract] [Full Text] [Related]
29. Unusual radioiodine uptake caused by metallic sutures in the skull in a patient with thyroid cancer.
Modoni S; Martino G; Guerra M; Frusciante V
Clin Nucl Med; 2000 Dec; 25(12):1053-4. PubMed ID: 11129153
[No Abstract] [Full Text] [Related]
30. Thymus accumulation of radioactive iodine.
Jackson GL; Graham WP; Flickinger FW; Kennedy TJ
Pa Med; 1979 Nov; 82(11):37-8. PubMed ID: 503536
[No Abstract] [Full Text] [Related]
31. SPECT/CT identification of post-radioactive iodine treatment false-positive uptake in a simple renal cyst.
Thust S; Fernando R; Barwick T; Mohan H; Clarke SE
Thyroid; 2009 Jan; 19(1):75-6. PubMed ID: 19119982
[No Abstract] [Full Text] [Related]
32. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
Paloyan E; Walker RP; Lawrence AM
Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
[TBL] [Abstract][Full Text] [Related]
33. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
[TBL] [Abstract][Full Text] [Related]
34. Thymic uptake after high-dose I-131 treatment in patients with differentiated thyroid carcinoma: a brief review of possible causes and management.
Arce MB; Molina TC; Hernández TM; de la Cinta Calvo Morón M; Herrero CH; De La Riva Pérez PA; Montaño JC
Endocrinol Nutr; 2015 Jan; 62(1):19-23. PubMed ID: 25160708
[TBL] [Abstract][Full Text] [Related]
35. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine.
Balachandran S; Sayle BA
Clin Nucl Med; 1981 Apr; 6(4):162-7. PubMed ID: 7214771
[TBL] [Abstract][Full Text] [Related]
36. Treatment of persistent or recurrent papillary carcinoma of the thyroid--the good, the bad, and the unknown.
Udelsman R
J Clin Endocrinol Metab; 2010 May; 95(5):2061-3. PubMed ID: 20444934
[No Abstract] [Full Text] [Related]
37. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
38. Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose.
Alibazoglu H; Alibazoglu B; Hollinger EF; Ingram SA; Willoughby WA; LaMonica G; Ali A
Clin Nucl Med; 1999 Aug; 24(8):597-600. PubMed ID: 10439182
[TBL] [Abstract][Full Text] [Related]
39. 131I treatment of thyroid papillary carcinoma in a patient with renal failure.
Morrish DW; Filipow LJ; McEwan AJ; Schmidt R; Murland KR; von Westarp C; Betcher KB
Cancer; 1990 Dec; 66(12):2509-13. PubMed ID: 2249192
[TBL] [Abstract][Full Text] [Related]
40. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
